XWELL (NASDAQ:XWEL) Announces Quarterly Earnings Results, Misses Expectations By $0.51 EPS

XWELL (NASDAQ:XWEL) issued its earnings results on Wednesday. The company reported ($1.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($1.00) by ($0.51), Zacks reports. XWELL had a negative net margin of 81.43% and a negative return on equity of 352.37%. The firm had revenue of $6.64 million during the quarter, compared to analyst estimates of $2.37 million.

XWELL Stock Performance

Shares of NASDAQ:XWEL opened at $1.45 on Friday. XWELL has a 52-week low of $0.26 and a 52-week high of $2.20. The company has a market capitalization of $11.49 million, a P/E ratio of -0.26 and a beta of 1.01. The company has a 50-day simple moving average of $1.28 and a 200 day simple moving average of $0.89.

Wall Street Analyst Weigh In

XWEL has been the subject of several recent analyst reports. Wall Street Zen downgraded shares of XWELL from a “hold” rating to a “sell” rating in a research note on Sunday, May 17th. Weiss Ratings downgraded shares of XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 13th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company currently has an average rating of “Sell”.

XWELL Company Profile

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.